Grant: Travel Awards - Institute Community Support

A surge in innovation in the field of genomic technology has made the use of genomic or pharmacogenomic testing an issue for primary care. These new tests must be evaluated prior to integration in primary care medicine. The objective of this project is to provide an effective methodology to assess communication and implementation barriers surrounding the use of new genomic and pharmacogenomic tests in primary care. The study will be comprised of two parts. The first part will involve deliberative consultations, which consist of an expert panel and focus group discussion, and a second aspect that will consist of two surveys evaluating the results of the deliberations. We will address the relevance and cognitive impact of using a new test in practice. We will be first testing these methods through evaluating a pharmacogenomic test for pediatric brain cancer. Family doctors and other end users of the test will be recruited. The results of this study will a generalizable framework that will ensure that a new genomic or pharmacogenomic test is appropriate for primary care.